| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.89B | +3.1% |
| Cost of Revenue | $2.64B | +7.0% |
| R&D Expense | $97.0M | +16.9% |
| SG&A Expense | $421.0M | +7.4% |
| Pre-tax Income | $647.0M | -18.8% |
| Income Tax | $362.0M | +88.5% |
| Net Income | $237.0M | -60.1% |
| EPS (Basic) | $1.49 | -60.2% |
| EPS (Diluted) | $1.49 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $534.0M | -19.2% |
| Accounts Receivable | $645.0M | +13.4% |
| Inventory | $715.0M | +28.1% |
| Current Assets | $2.39B | +28.3% |
| Total Assets | $5.67B | +13.4% |
| Current Liabilities | $1.71B | +58.2% |
| Long-term Debt | $2.00B | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $455.0M | -46.0% |
| Capital Expenditures | $336.0M | +13.5% |
| Investing Cash Flow | -$330.0M | -10.7% |
| Financing Cash Flow | -$235.0M | +48.1% |
| Free Cash Flow | $119.0M | -78.2% |
| -60.2% |
| Total Liabilities |
| $4.30B |
| +135.8% |
| Stockholders' Equity | $1.41B | -56.7% |